Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, J.-Y.
Right arrow Articles by Yang, P.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, J.-Y.
Right arrow Articles by Yang, P.-C.
Clinical Cancer Research Vol. 11, 8070-8078, November 15, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

Jin-Yuan Shih1, Meng-Feng Tsai1, Tzu-Hua Chang1, Yih-Leong Chang2, Ang Yuan3, Chong-Jen Yu1, Shin-Bey Lin1, Geou-Yarh Liou1, Meng-Larn Lee5, Jeremy J.W. Chen6,8, Tse-Ming Hong5, Shuenn-Chen Yang5, Jen-Liang Su7, Yung-Chie Lee4 and Pan-Chyr Yang1,5,6,9

Authors' Affiliations: Departments of 1 Internal Medicine, 2 Pathology, 3 Emergency Medicine, and 4 Surgery, National Taiwan University Hospital; 5 Institute of Biomedical Sciences, Academia Sinica; 6 NTU Center for Genomic Medicine and 7 Institute of Toxicology, National Taiwan University College of Medicine; 8 Institutes of Biomedical Sciences and Molecular Biology, National Chung-Hsing University; and 9 National Health Research Institute, Taipei, Taiwan

Requests for reprints: Pan-Chyr Yang, Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei 100, Taiwan. Phone: 886-2-23562905; Fax: 886-2-23582867; E-mail: pcyang{at}ha.mc.ntu.edu.tw.

Purpose: In a previous genome-wide gene expression profiling analysis using an invasion cancer cell lines model, we have identified Slug as selectively overexpressed in the highly invasive cancer cells. Here, we investigated the clinical significance of Slug in lung adenocarcinoma and the role of Slug in the process of cancer cell invasion and metastasis.

Experimental Design: Real-time quantitative reverse transcription-PCR was used to investigate Slug mRNA in surgically resected lung adenocarcinoma of 54 patients and its correlation with survival. We overexpressed Slug in a lung adenocarcinoma cell line with very low Slug levels and investigated the in vitro and in vivo effects of Slug expression.

Results: High expression of Slug mRNA in lung cancer tissue was significantly associated with postoperative relapse (P = 0.03) and shorter patient survival (P < 0.001). The overexpression of Slug enhanced xenograft tumor growth and increased microvessel counts in angiogenesis assay. Both inducible and constitutive overexpression of Slug suppressed the expression of E-cadherin and increased the in vitro invasive ability. Zymography revealed increased matrix metalloproteinase-2 activity in Slug overexpressed cells. ELISA, reverse transcription-PCR, and immunohistochemistry confirmed the increase of matrix metalloproteinase-2 proteins and mRNA in Slug overexpressed cells and xenograft tumors.

Conclusions: Slug expression can predict the clinical outcome of lung adenocarcinoma patients. Slug is a novel invasion-promoting gene in lung adenocarcinoma.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Kim, H. J. Lee, H. Y. Choi, Y. Shin, S. Nam, G. Seo, D.-S. Son, J. Jo, J. Kim, J. Lee, et al.
Clinical Validity of the Lung Cancer Biomarkers Identified by Bioinformatics Analysis of Public Expression Data
Cancer Res., August 1, 2007; 67(15): 7431 - 7438.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. Leroy and K. E. Mostov
Slug Is Required for Cell Survival during Partial Epithelial-Mesenchymal Transition of HGF-induced Tubulogenesis
Mol. Biol. Cell, May 1, 2007; 18(5): 1943 - 1952.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Come, F. Magnino, F. Bibeau, P. De Santa Barbara, K. F. Becker, C. Theillet, and P. Savagner
Snail and Slug Play Distinct Roles during Breast Carcinoma Progression.
Clin. Cancer Res., September 15, 2006; 12(18): 5395 - 5402.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. S. El-Deiry, C. C. Sigman, and G. J. Kelloff
Imaging and Oncologic Drug Development
J. Clin. Oncol., July 10, 2006; 24(20): 3261 - 3273.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-F. Tsai, C.-C. Wang, G.-C. Chang, C.-Y. Chen, H.-Y. Chen, C.-L. Cheng, Y.-P. Yang, C.-Y. Wu, F.-Y. Shih, C.-C. Liu, et al.
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
J Natl Cancer Inst, June 21, 2006; 98(12): 825 - 838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.